Pfizer 10K 2001 Annual report | PFE Filing

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	6th grade Avg

New words: ACE, Acton, affiliate, Africa, agitated, Agouron, aimed, Air, Alex, AmerisourceBergen, amortized, andAricept, andFemhrt, andGeodon, andListerine, andMax, andNamed, andZyrtec, angiotensin, Ann, antibioticTrovan, antiretroviral, Arbor, asDiflucan, assigned, asterisk, asZeldox, attached, audit, Aurora, Baja, begun, Benadryl, Bend, Bextra, bioterrorism, Blacksburg, bladeXtreme, Blue, breached, breath, Burt, byRezulin, Cambridge, Capsugel, capsule, Card, cent, Chancery, Characterization, characterized, CHC, chewing, choice, chrysotile, classified, clothing, ComplementingDiflucan, comply, composition, concerningNeurontin, concluding, confectionery, congestion, congestive, consortium, Constraintsaffect, context, contraceptive, cough, coveringNeurontin, decongestant, detection, Diflucanand, DiflucanandZoloftare, discount, distinguished, divisional, dysphoric, EITF, elderly, Elk, empty, ensue, ensure, entitledFinancial, entitledLease, enzyme, epilepsy, Euronext, evidentiary, excessive, exploring, False, familial, fatal, Fe, finite, fish, Foran, forLipitor, formal, forRelpax, forRezulin, Fort, forVfend, Freiburg, FTC, gabapentin, gelatin, Germany, Gibsonburg, GLPC, goodwill, grand, Greenwood, Grove, Guilderland, headingBanking, headingProduct, headingRelated, headingSummary, healthcare, heavily, highly, HIV, Holland, hormone, Howell, Ice, impurity, inception, includeGlucotrol, includingTetraMin, indefinite, indoor, inGovernment, inhibitor, inMarketing, instance, insulin, intangible, internationally, intramuscular, involvingRezulin, IRC, isVfend, Jeffrey, Jolla, justified, kind, Kindler, La, lactam, latent, launchedGeodon, launchedZeldox, Leadership, legacy, Lime, Lititz, Living, logo, Lorch, Managementon, Manchester, Mandl, manicure, Margaret, Marietta, marketedRezulin, maximum, McDonald, media, Melle, menstrual, Milford, military, mind, misled, Mississauga, Mitchell, mood, mouthwash, nameReactine, nasal, NDA, Neurontin, neuropathic, NJDEP, Norton, ofCelebrex, ofCelebrexalso, ofDentyne, ofDiflucan, offerZoloft, ofGeodon, ofListerine, ofNeurontin, ofRevolution, ofRezulin, ofSudafed, ofTrovan, ofVfend, ofZithromax, ofZoloft, Ontario, Operationon, Optical, option, ornamental, ourBarbasol, outdoor, outpatient, pancreatic, partial, partially, Partner, PBM, peer, Perio, Pharmacia, physically, physiology, Ploermel, pooling, pregnancy, premenstrual, productAricept, productCelebrex, productRevolution, productsZyrtec, protease, Protector, purpose, razor, real, record, regular, Remune, Reseller, resistance, restated, Rezulin, Robert, Rochester, Rockford, sampling, Sankyo, Schick, schizophrenia, SeeGovernment, sellingVfend, sellZyrtec, Shield, simple, Singapore, singly, stable, statute, stimulator, stockpile, struck, study, successor, suncare, supply, surveillance, Sweden, switched, switchZyrtec, Sword, tableGeographic, tablePercentage, tangible, targetedZyrtec, Task, Team, terrorist, testimony, Tetra, thatRezulin, theBain, TheRezulin, theRid, theseNeurontin, threat, toDiflucan, toiletry, toNeurontin, toRezulin, tort, triple, true, underlying, understand, underway, unfair, urogenital, USEPA, Vega, vendor, Vermont, vicinity, vigorously, Viracept, virtually, vital, water, weaker, Wellpoint, Wilkinson, withdrawn, Worth

Removed: accepted, acetabular, additive, advanced, advisory, AG, agreed, al, Alabama, alan, Algeria, Alza, amendment, Analyst, appealed, arising, Asia, asserting, assumed, Auditor, Australasia, barrett, beginning, Belgium, belief, body, bovishield, bowler, bowling, Brazil, Brazilian, brian, calcium, calculating, call, career, cattle, CCR, certified, certify, Chair, channel, check, Circuit, closing, Columbia, comprised, Computation, computed, Concave, consultation, controller, convened, Convexo, County, Craig, credit, daily, damage, declaratory, declining, dectomax, defectively, defined, derivative, diabinese, disposing, dramatic, eastern, Egypt, eleven, eligible, employ, Employer, encompassing, ended, entitling, exclude, exclusive, expensed, extension, faith, feed, fifteen, final, Finance, focusing, found, fracture, frederick, functioning, fund, funded, gary, Geographically, glucotrol, governing, grown, guaranteed, Harvey, heavy, hip, hold, holding, hospital, Howmedica, implantable, implanted, implementing, inactive, incorporating, incur, installed, intended, intrinsically, joint, jortner, Juan, judge, kelly, kenneth, Kenya, knowledge, labrecque, leukocell, levin, liable, limitation, Ltda, manager, mechanism, merit, Mexico, Miller, milne, minimal, misbranded, Mohand, moral, Morocco, motion, nifedipine, Ohio, panel, par, paratect, patrick, Paul, payable, payment, penile, personal, pertaining, planning, plax, policy, possession, poultry, Pratt, preceding, principle, promoted, properly, prophylactic, punitive, purportedly, questioned, Ratio, reactine, reaction, recognized, refractory, refund, remain, remedy, repealed, representative, reserve, resolve, resulted, retailer, returned, rid, robison, Roerig, San, satisfaction, satisfied, Saxton, Scientist, serving, settle, sheet, shiley, shorter, Sidi, specialty, stafac, stating, stay, strive, subpoena, subsequent, subsequently, sum, swine, talc, terramycin, transfer, transferred, Treasurer, twenty, undisclosed, unlawfully, unreimbursed, untrue, valbazen, valve, vanguard, variously, view, virginiamycin, washington, wholly, withheld, written

•		Form S-8 dated October 27, 1983 (File No. 2-87473),

•		Form S-8 dated March 22, 1990 (File No. 33-34139),

•		Form S-8 dated January 24, 1991 (File No. 33-38708),

•		Form S-8 dated November 18, 1991 (File No. 33-44053),

•		Form S-3 dated May 27, 1993 (File No. 33-49629),

•		Form S-8 dated May 27, 1993 (File No. 33-49631),

•		Form S-8 dated May 19, 1994 (File No. 33-53713),

•		Form S-8 dated October 5, 1994 (File No. 33-55771),

•		Form S-3 dated November 14, 1994 (File No. 33-56435),

•		Form S-8 dated December 20, 1994 (File No. 33-56979),

•		Form S-4 dated February 14, 1995 (File No. 33-57709),

•		Form S-8 dated March 29, 1996 (File No. 333-02061),

•		Form S-8 dated September 25, 1997 (File No. 333-36371),

•		Form S-8 dated April 24, 1998 (File No. 333-50899),

•		Form S-8 dated April 22, 1999 (File No. 333-76839),

•		Form S-4 dated March 9, 2000 (File No. 333-90975),

•		Form S-8 dated June 19, 2000 (File No. 333-90975),

•		Form S-8 dated June 19, 2000 (File No. 333-39606),

•		Form S-8 dated June 19, 2000 (File No. 333-39610),

•		Form S-3 dated October 20, 2000 (File No. 333-48382),

•		Form S-8 dated April 27, 2001 (File No. 333-59654), and

•		Form S-8 dated April 27, 2001 (File No. 333-59660).

Pfizer (PFE) 10-K2001 FY Annual report

Content analysis